Glycobiology Market by Application, Product and Geography - Forecast and Analysis 2023-2027

Published: Oct 2023 Pages: 165 SKU: IRTNTR72392

Glycobiology Market Forecast 2023-2027

The Global Glycobiology Market size is estimated to grow by USD 1,473.84 million, at a CAGR of 15.06% between 2022 and 2027. 

There is significant growth across pharmaceutical and biotechnology companies due to the rise in R&D activities such as glycomics & glycobiology and proteomics research. Additionally, there is growing traction for glycobiology in key areas such as (neurobiology, development, and immunology and several applications including biotherapy, antibodies, and the production of heparin analogs). As carbohydrates are bound to glycolipids or glycoproteins, it decides the properties and fate of living cells. One of the main methods for understanding the functional properties of glycoproteins is the purification of targets from recombinant expression systems. Furthermore, there are 76 research/academic institutes, and nearly 145 research labs supporting core proteomic research across India. Hence, such factors are positively impacting the market growth.

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.

What will be the size of the Glycobiology Market During the Forecast Period?

To learn more about this report, Request Free Sample

Segmentation by  Application, Product, and Geography Analysis

Application Analysis

Drug discovery and development

The drug discovery and development segment is estimated to witness significant growth during the forecast period. There is extensive use of glycobiology for drug discovery and development. Glycans are important for several biological processes and they are visible as simple monosaccharides or form more complex structures, including naturally occurring complex carbohydrates in which the sugar moiety is attached to a protein or lipid.

Get a glance at the market contribution of various segments View a PDF Sample

The drug discovery and development segment was the largest segment and was valued at USD 437.88 million in 2017. Carbohydrates play a major role in many biological processes such as acting as the most abundant molecule in the body, an energy source for glucose metabolism, or a structural cell wall component. Complex glycans are needed to fold newly synthesized polypeptides properly and are essential in the final stability, solubility, and transport of the glycoprotein. Additionally, carbohydrates are present on the surface of all cell types, targeting vital biological functions that rely on the specific recognition of glycan structure by other biomolecules. Several advances in mass spectrometry (MS) equipment will allow the mapping of glycan attachment sites, profiling of glycan structural variations, and determining detailed carbohydrate microstructures. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.

Product Analysis

Enzymes

Enzymes play a major role in glycobiology. For instance, transferase is a vital component in the complex generation of carbohydrates. In addition, these carbohydrates which are generated are metabolized by glycosidases and altered by a range of other enzymes including sulfatases. Additionally, these enzymes can be utilized as a tool to elucidate the structure and function of carbohydrates. Thus the rising incidences of drug discovery and development are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.

Instruments

Glycobiology is essentially a branch of science that is the study of the structure, biology, and function of glycans which are present in all living organisms. This study enables drug discovery as well as diagnosis of disease along with therapeutic applications. Additionally, this study needs instruments including microscopes, flow cytometric cell sorting/purification, ELISA, and fluorescent immunohistochemistry. The rising adoption of glycobiology in disease diagnosis is a significant factor fuelling the growth of this segment which in turn will drive the market growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. One of the main factors contributing to the significant growth of the global market in North America is the presence of key pharmaceutical and biopharmaceutical companies. Additionally, the regional market is driven by the presence of well-established healthcare infrastructure and accessibility to advanced products. Furthermore, there is an increasing application of glycans for various cancer treatments as well as increasing funding from government organizations to improve the field of glycobiology will fuel the market growth in the region during the forecast period.

Buy Now Full Report and Discover More

Key Glycobiology Market Companies 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Agilent Technologies Inc: The company offers glycobiology products such as glycobiology enzymes for N-glycan workflows.

  • Asparia Glycomics
  • Bio-Techne Corp
  • Bruker Corp.
  • CD BioGlyco
  • Chemily Glycoscience
  • Genovis AB
  • ICE S.p.a.
  • Lectenz Bio
  • Ludger Ltd.
  • Merck KGaA
  • New England Biolabs Inc.
  • NZYTech
  • Plexera LLC
  • Shimadzu Corp.
  • Sumitomo Bakelite Co. Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corp.
  •  ZBiotech

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Market Drivers

One of the key factors driving the market growth is the increase in expenditure by different pharmaceutical companies on R&D. There is increasing investment by several pharmaceutical companies in R&D which include glycomics & glycobiology as well as proteomics research. The average spending of pharmaceutical companies is about 15%-20% of their revenue for R&D purposes. As a result of this R&D spending, it brings several products into the market.

Moreover, it has led to an increase in the demand for pharmaceutical contract packaging. With the adoption of contract packaging,  pharmaceutical manufacturers can minimize their capital expenditure and operating cost related to the purchasing of packaging machinery, space for setting up packaging units, and labor costs for the same. Thus, it is positively impacting the market growth. Hence, such factors are expected to drive market growth during the forecast period.

Significant Market Trends

A key factor shaping the market growth is the growing demand for glycomics products for drug discovery and development. Glycans play a vital role in several biological processes. These are important for protein folding and stability and serve as cognitive elements of cell-cell and cell-matrix interactions. Complex glycans play an essential role in the expression of the phenotype of the genotype of the cell and they are mainly present on the surface of cells, deposited in the extracellular matrix, and bound to soluble signaling molecules.

There is an increasing focus on glycans as it has become the center of medically relevant biological processes and is perceived as hotspots for biomedical interventions. Several technological advancements in biophysical technology offer biophysical technology to improve the molecular and structural understanding of these processes and have resulted in the development of effective therapies. Hence, such factors are expected to drive market growth during the forecast period.

Major Market Challenges

The low availability of skilled professionals is one of the key challenges hindering market growth. The drug development process is very risky as well as costly and time-consuming at the same time. Thus it is essential to have well-trained skilled professionals involved in such kinds of experiments and research. Laboratory professionals are essentially skilled and certified professionals who are well-trained in the theoretical and practical aspects of glycobiology.

However, the role of glycobiology professionals spans several areas including staff technologists, research technologists, supervisors, managers, and educators. Several of these professionals lack knowledge about technology and its benefits. As a result, it increases the chances of error or failure in the process. Hence, such factors are expected to hinder market growth during the forecast period.

Buy Now Full Report and Discover More

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the market growth and trends opportunities from 2017 to 2027. 

  • Application Outlook (USD Million, 2017 - 2027)
    • Drug discovery and development
    • Disease diagnostics
    • Others
  • Product Outlook (USD Million, 2017 - 2027)
    • Enzymes
    • Instruments
    • Reagents
    • Kits
  • Geography Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Australia
      • Argentina
      • Brazil

Market Analyst Overview

The market is at the forefront of research, particularly in understanding the interaction between the coronavirus transmembrane spike (S) glycoprotein and the ACE2 receptor, crucial for viral entry. Research studies, such as those conducted at the RIKEN Center for Computational Science (R-CCS) and published in the Journal of Molecular Biology, are advancing our knowledge of these interactions.

Glycobiology also explores the role of glycan-binding proteins, glycan antigens, and anti-glycan antibodies in health and disease, including their potential as targets for therapeutics. Institutions like Griffith University's Institute for Glycomics and initiatives like the Australian Cancer Research Foundation (ACRF) International Centre for Cancer Glycomics and GlycoNet are at the forefront of this research, focusing on cancer development and other chronic diseases. The field also encompasses molecular diagnosis, vaccine development, and drug delivery systems, aiming to translate research into effective treatments.

Glycobiology Market Scope

Report Coverage

Details

Page number

165

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 15.06%

Market growth 2023-2027

USD 1,473.84 million

Market structure

Fragmented

YoY growth 2022-2023(%)

14.32

Regional analysis

North America, Europe, Asia, and the Rest of the World (ROW)

Performing market contribution

North America at 43%

Key countries

US, Canada, Germany, UK, and China

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Agilent Technologies Inc., Asparia Glycomics, Bio-Techne Corp., Bruker Corp., CD BioGlyco, Chemily Glycoscience, Genovis AB, ICE S.p.a., Lectenz Bio, Ludger Ltd., Merck KGaA, New England Biolabs Inc., NZYTech, Plexera LLC, Shimadzu Corp., Sumitomo Bakelite Co. Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc., Waters Corp., and ZBiotech

Market dynamics

Parent market analysis, Market Forecasting Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the market forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
  • Precise estimation of the size of the market size and its contribution to the parent market
  • Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
  • Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
  • Thorough market growth analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive market analysis and report on the factors that will challenge the market research and growth of market vendors

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global glycobiology market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global glycobiology market 2017 - 2021 ($ million)
    • 4.2 Application Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ million)
    • 4.3 Product Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Application

    • 6.1 Market segments
      • Exhibit 30: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
    • 6.2 Comparison by Application
      • Exhibit 32: Chart on Comparison by Application
      • Exhibit 33: Data Table on Comparison by Application
    • 6.3 Drug discovery and development - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Drug discovery and development - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Drug discovery and development - Year-over-year growth 2022-2027 (%)
    • 6.4 Disease diagnostics - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Disease diagnostics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Disease diagnostics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Disease diagnostics - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Disease diagnostics - Year-over-year growth 2022-2027 (%)
    • 6.5 Others - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.6 Market opportunity by Application
      • Exhibit 46: Market opportunity by Application ($ million)
      • Exhibit 47: Data Table on Market opportunity by Application ($ million)

    7 Market Segmentation by Product

    • 7.1 Market segments
      • Exhibit 48: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 49: Data Table on Product - Market share 2022-2027 (%)
    • 7.2 Comparison by Product
      • Exhibit 50: Chart on Comparison by Product
      • Exhibit 51: Data Table on Comparison by Product
    • 7.3 Enzymes - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Enzymes - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Data Table on Enzymes - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Chart on Enzymes - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Enzymes - Year-over-year growth 2022-2027 (%)
    • 7.4 Instruments - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Instruments - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
    • 7.5 Reagents - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Reagents - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Data Table on Reagents - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Chart on Reagents - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Reagents - Year-over-year growth 2022-2027 (%)
    • 7.6 Kits - Market size and forecast 2022-2027
      • Exhibit 64: Chart on Kits - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Data Table on Kits - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Chart on Kits - Year-over-year growth 2022-2027 (%)
      • Exhibit 67: Data Table on Kits - Year-over-year growth 2022-2027 (%)
    • 7.7 Market opportunity by Product
      • Exhibit 68: Market opportunity by Product ($ million)
      • Exhibit 69: Data Table on Market opportunity by Product ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 71: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 72: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 73: Chart on Geographic comparison
      • Exhibit 74: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 UK - Market size and forecast 2022-2027
      • Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.10 Canada - Market size and forecast 2022-2027
      • Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.11 China - Market size and forecast 2022-2027
      • Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 111: Market opportunity by geography ($ million)
      • Exhibit 112: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 113: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 115: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 116: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 117: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 118: Matrix on vendor position and classification
            • 12.3 Agilent Technologies Inc.
              • Exhibit 119: Agilent Technologies Inc. - Overview
              • Exhibit 120: Agilent Technologies Inc. - Business segments
              • Exhibit 121: Agilent Technologies Inc. - Key offerings
              • Exhibit 122: Agilent Technologies Inc. - Segment focus
            • 12.4 Asparia Glycomics
              • Exhibit 123: Asparia Glycomics - Overview
              • Exhibit 124: Asparia Glycomics - Product / Service
              • Exhibit 125: Asparia Glycomics - Key offerings
            • 12.5 Bio Techne Corp.
              • Exhibit 126: Bio Techne Corp. - Overview
              • Exhibit 127: Bio Techne Corp. - Business segments
              • Exhibit 128: Bio Techne Corp. - Key news
              • Exhibit 129: Bio Techne Corp. - Key offerings
              • Exhibit 130: Bio Techne Corp. - Segment focus
            • 12.6 Bruker Corp.
              • Exhibit 131: Bruker Corp. - Overview
              • Exhibit 132: Bruker Corp. - Business segments
              • Exhibit 133: Bruker Corp. - Key news
              • Exhibit 134: Bruker Corp. - Key offerings
              • Exhibit 135: Bruker Corp. - Segment focus
            • 12.7 Chemily Glycoscience
              • Exhibit 136: Chemily Glycoscience - Overview
              • Exhibit 137: Chemily Glycoscience - Product / Service
              • Exhibit 138: Chemily Glycoscience - Key offerings
            • 12.8 ICE S.p.a.
              • Exhibit 139: ICE S.p.a. - Overview
              • Exhibit 140: ICE S.p.a. - Product / Service
              • Exhibit 141: ICE S.p.a. - Key offerings
            • 12.9 Lectenz Bio
              • Exhibit 142: Lectenz Bio - Overview
              • Exhibit 143: Lectenz Bio - Product / Service
              • Exhibit 144: Lectenz Bio - Key offerings
            • 12.10 Merck KGaA
              • Exhibit 145: Merck KGaA - Overview
              • Exhibit 146: Merck KGaA - Business segments
              • Exhibit 147: Merck KGaA - Key news
              • Exhibit 148: Merck KGaA - Key offerings
              • Exhibit 149: Merck KGaA - Segment focus
            • 12.11 New England Biolabs Inc.
              • Exhibit 150: New England Biolabs Inc. - Overview
              • Exhibit 151: New England Biolabs Inc. - Product / Service
              • Exhibit 152: New England Biolabs Inc. - Key news
              • Exhibit 153: New England Biolabs Inc. - Key offerings
            • 12.12 Plexera LLC
              • Exhibit 154: Plexera LLC - Overview
              • Exhibit 155: Plexera LLC - Product / Service
              • Exhibit 156: Plexera LLC - Key offerings
            • 12.13 Shimadzu Corp.
              • Exhibit 157: Shimadzu Corp. - Overview
              • Exhibit 158: Shimadzu Corp. - Business segments
              • Exhibit 159: Shimadzu Corp. - Key news
              • Exhibit 160: Shimadzu Corp. - Key offerings
              • Exhibit 161: Shimadzu Corp. - Segment focus
            • 12.14 Sumitomo Bakelite Co. Ltd.
              • Exhibit 162: Sumitomo Bakelite Co. Ltd. - Overview
              • Exhibit 163: Sumitomo Bakelite Co. Ltd. - Business segments
              • Exhibit 164: Sumitomo Bakelite Co. Ltd. - Key offerings
              • Exhibit 165: Sumitomo Bakelite Co. Ltd. - Segment focus
            • 12.15 Takara Bio Inc.
              • Exhibit 166: Takara Bio Inc. - Overview
              • Exhibit 167: Takara Bio Inc. - Product / Service
              • Exhibit 168: Takara Bio Inc. - Key offerings
            • 12.16 Thermo Fisher Scientific Inc.
              • Exhibit 169: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 170: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 171: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 172: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 173: Thermo Fisher Scientific Inc. - Segment focus
            • 12.17 ZBiotech
              • Exhibit 174: ZBiotech - Overview
              • Exhibit 175: ZBiotech - Product / Service
              • Exhibit 176: ZBiotech - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 177: Inclusions checklist
                • Exhibit 178: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 179: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 180: Research methodology
                • Exhibit 181: Validation techniques employed for market sizing
                • Exhibit 182: Information sources
              • 13.5 List of abbreviations
                • Exhibit 183: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              glycobiology market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis